Literature DB >> 27461456

Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].

Pierre Van Damme1, Paolo Bonanni2, F Xavier Bosch3, Elmar Joura4, Susanne Krüger Kjaer5, Chris J L M Meijer6, Karl-Ulrich Petry7, Benoit Soubeyrand8, Thomas Verstraeten9, Margaret Stanley10.   

Abstract

Entities:  

Year:  2016        PMID： 27461456     DOI： 10.1016/j.vaccine.2016.07.035

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  2 in total

Review 1.  Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine.

Authors:  Alice S Forster; Jo Waller
Journal:  Eur J Cancer       Date:  2016-05-26       Impact factor: 9.162

2.  The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study.

Authors:  Abraham Campos-Romero; Karen S Anderson; Adhemar Longatto-Filho; Marco A Luna-Ruiz Esparza; David J Morán-Portela; Javier A Castro-Menéndez; José L Moreno-Camacho; Diana Y Calva-Espinosa; Manuel A Acosta-Alfaro; Freddy A Meynard-Mejía; Marlene Muñoz-Gaitán; Jonathan Alcántar-Fernández
Journal:  Sci Rep       Date:  2019-07-12       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.